-
1
-
-
0025952455
-
Recent advances in the phencyclidine model of schizophrenia
-
Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-1308
-
(1991)
Am J Psychiatry
, vol.148
, pp. 1301-1308
-
-
Javitt, D.C.1
Zukin, S.R.2
-
2
-
-
0032403626
-
D-serine added to antipsychotics for the treatment of schizophrenia
-
Tsai G, Yang P, Chung LC, Lange N, Coyle JT. D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998;44:1081-1089
-
(1998)
Biol Psychiatry
, vol.44
, pp. 1081-1089
-
-
Tsai, G.1
Yang, P.2
Chung, L.C.3
Lange, N.4
Coyle, J.T.5
-
3
-
-
0032925438
-
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
-
Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 1999;56:29-36
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 29-36
-
-
Heresco-Levy, U.1
Javitt, D.C.2
Ermilov, M.3
Mordel, C.4
Silipo, G.5
Lichtenstein, M.6
-
4
-
-
9244243064
-
Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis
-
Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis. Schizophr Res 2005;72:225-234
-
(2005)
Schizophr Res
, vol.72
, pp. 225-234
-
-
Tuominen, H.J.1
Tiihonen, J.2
Wahlbeck, K.3
-
5
-
-
0030919910
-
Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes
-
Supplisson S, Bergman C. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J Neurosci 1997;17:4580-4590
-
(1997)
J Neurosci
, vol.17
, pp. 4580-4590
-
-
Supplisson, S.1
Bergman, C.2
-
6
-
-
1542617755
-
Inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
-
Tsai G, Lane HY, Yang P, Chong MY, Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2004;55:452-456
-
(2004)
Biol Psychiatry
, vol.55
, pp. 452-456
-
-
Tsai, G.1
Lane, H.Y.2
Yang, P.3
Chong, M.Y.4
Lange, N.5
Glycine Transporter, I.6
-
7
-
-
27744529018
-
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: A randomized, double-blind, placebo-controlled study
-
Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: A randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry 2005;62:1196-1204
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 1196-1204
-
-
Lane, H.Y.1
Chang, Y.C.2
Liu, Y.C.3
Chiu, C.C.4
Tsai, G.E.5
-
8
-
-
81055156867
-
Millan MJ. Simultaneous quantification of d- vs. l-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: Differential modulation by N-methyl-d-aspartate (NMDA) and other pharmacological agents
-
Gobert A, Rivet JM, Billiras R, Parsons F, Millan MJ. Simultaneous quantification of d- vs. l-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: Differential modulation by N-methyl-d-aspartate (NMDA) and other pharmacological agents. J Neurosci Methods 2011;202:143-157
-
(2011)
J Neurosci Methods
, vol.202
, pp. 143-157
-
-
Gobert, A.1
Rivet, J.M.2
Billiras, R.3
Parsons, F.4
-
9
-
-
40949145164
-
Functional co-primary measures for clinical trials in schizophrenia: Results from the MATRICS Psychometric and Standardization
-
Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR Functional co-primary measures for clinical trials in schizophrenia: Results from the MATRICS Psychometric and Standardization Study Am J Psychiatry 2008;165:221-228
-
(2008)
Study am J Psychiatry
, vol.165
, pp. 221-228
-
-
Green, M.F.1
Nuechterlein, K.H.2
Kern, R.S.3
Baade, L.E.4
Fenton, W.S.5
Gold, J.M.6
Keefe, R.S.7
Mesholam-Gately, R.8
Seidman, L.J.9
Stover, E.10
Marder, S.R.11
-
10
-
-
60149091657
-
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
-
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457(7231):910-914
-
(2009)
Nature
, vol.457
, Issue.7231
, pp. 910-914
-
-
Sreekumar, A.1
Poisson, L.M.2
Rajendiran, T.M.3
Khan, A.P.4
Cao, Q.5
Yu, J.6
Laxman, B.7
Mehra, R.8
Lonigro, R.J.9
Li, Y.10
Nyati, M.K.11
Ahsan, A.12
Kalyana-Sundaram, S.13
Han, B.14
Cao, X.15
Byun, J.16
Omenn, G.S.17
Ghosh, D.18
Pennathur, S.19
Alexander, D.C.20
Berger, A.21
Shuster, J.R.22
Wei, J.T.23
Varambally, S.24
Beecher, C.25
Chinnaiyan, A.M.26
more..
-
11
-
-
77951849434
-
Serum sarcosine is not a marker for prostate cancer
-
Struys EA, Heijboer AC, van Moorselaar J, Jakobs C, Blankenstein MA. Serum sarcosine is not a marker for prostate cancer. Ann Clin Biochem 2010;47:282
-
(2010)
Ann Clin Biochem
, vol.47
-
-
Struys, E.A.1
Heijboer, A.C.2
Van Moorselaar, J.3
Jakobs, C.4
Blankenstein, M.A.5
-
12
-
-
0003575871
-
-
New York: Biometrics Research, New York State Psychiatric Institute
-
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders (SCID). New York: Biometrics Research, New York State Psychiatric Institute, 1997
-
(1997)
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)
-
-
First, M.B.1
Spitzer, R.L.2
Gibbon, M.3
Williams, J.4
-
13
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
-
(1987)
Schizophr Bull
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
15
-
-
0001721056
-
Predicting premorbid IQ: A revision of the national adult reading test
-
Blair JR, Spreen O. Predicting premorbid IQ: A revision of the national adult reading test. Clinical Neuropsychologist 1989;3:129-136
-
(1989)
Clinical Neuropsychologist
, vol.3
, pp. 129-136
-
-
Blair, J.R.1
Spreen, O.2
-
16
-
-
1942536959
-
The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery
-
Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004;68:283-297
-
(2004)
Schizophr Res
, vol.68
, pp. 283-297
-
-
Keefe, R.S.1
Goldberg, T.E.2
Harvey, P.D.3
Gold, J.M.4
Poe, M.P.5
Coughenour, L.6
-
17
-
-
84939438720
-
Manual of Directions and Scoring
-
Army Individual Test Battery, editor. Washington, D.C.: U.S. War Department
-
Army Individual Test Battery: Manual of Directions and Scoring. Office AGs, editor. Washington, D.C.: U.S. War Department, 1944
-
(1944)
Office Ags
-
-
-
18
-
-
0023790621
-
The Continuous Performance Test, identical pairs version (CPT-IP)
-
Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L The Continuous Performance Test, identical pairs version (CPT-IP): I New findings about sustained attention in normal families. Psychiatry Res 1988;26:223-238
-
(1988)
I New Findings about Sustained Attention in Normal Families. Psychiatry Res
, vol.26
, pp. 223-238
-
-
Cornblatt, B.A.1
Risch, N.J.2
Faris, G.3
Friedman, D.4
Erlenmeyer-Kimling, L.5
-
19
-
-
0031025773
-
Weinberger DR Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia
-
Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997;54:159-165
-
(1997)
Arch Gen Psychiatry
, vol.54
, pp. 159-165
-
-
Gold, J.M.1
Carpenter, C.2
Randolph, C.3
Goldberg, T.E.4
-
21
-
-
0008253199
-
-
Psychological Assessment Resources, Inc
-
Brandt J, Benedict RHB. The Hopkins Verbal Learning Test-Revised Odessa, FL, USA: Psychological Assessment Resources, Inc., 2001
-
(2001)
The Hopkins Verbal Learning Test-Revised Odessa, FL, USA
-
-
Brandt, J.1
Benedict, R.2
-
22
-
-
84939427929
-
-
Benedict RHB. Brief Visuospatial Memory Test - Revised. Odessa, FL, Psychological Assessment Resources, Inc
-
Benedict RHB. Brief Visuospatial Memory Test - Revised. Odessa, FL, USA: Psychological Assessment Resources, Inc., 1997
-
(1997)
USA
-
-
-
24
-
-
0027382157
-
Rey Auditory-Verbal Learning Test: Structure analysis
-
Vakil E, Blachstein H. Rey Auditory-Verbal Learning Test: Structure analysis. J Clin Psychol 1993;49:883-890
-
(1993)
J Clin Psychol
, vol.49
, pp. 883-890
-
-
Vakil, E.1
Blachstein, H.2
-
27
-
-
0017750168
-
Clinical research techniques in tardive dyskinesia
-
Fann WE, Stafford JR, Malone RL, Frost JD, Richman BW. Clinical research techniques in tardive dyskinesia. Am J Psychiatry 1977;134:759-762
-
(1977)
Am J Psychiatry
, vol.134
, pp. 759-762
-
-
Fann, W.E.1
Stafford, J.R.2
Malone, R.L.3
Frost, J.D.4
Richman, B.W.5
-
30
-
-
78651318867
-
Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
-
Jentzmik F, Stephan C, Lein M, Miller K, Kamlage B, Bethan B, Kristiansen G, Jung K. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. J Urol 2011;185:706-711
-
(2011)
J Urol
, vol.185
, pp. 706-711
-
-
Jentzmik, F.1
Stephan, C.2
Lein, M.3
Miller, K.4
Kamlage, B.5
Bethan, B.6
Kristiansen, G.7
Jung, K.8
-
31
-
-
36849071470
-
Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
-
Lane HY, Liu YC, Huang CL, Chang YC, Liau CH, Perng CH, Tsai GE. Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study. Biol Psychiatry 2008 1;63:9-12
-
Biol Psychiatry 2008 1
, vol.63
, pp. 9-12
-
-
Lane, H.Y.1
Liu, Y.C.2
Huang, C.L.3
Chang, Y.C.4
Liau, C.H.5
Perng, C.H.6
Tsai, G.E.7
-
32
-
-
77953545879
-
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
-
Lane HY, Lin CH, Huang YJ, Liao CH, Chang YC, Tsai GE. A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia Int J Neuropsychopharmacol 2010;13:451-460
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 451-460
-
-
Lane, H.Y.1
Lin, C.H.2
Huang, Y.J.3
Liao, C.H.4
Chang, Y.C.5
Tsai, G.E.6
-
33
-
-
79953316447
-
Glycine transporter-1: A new potential therapeutic target for schizophrenia
-
Hashimoto K. Glycine transporter-1: A new potential therapeutic target for schizophrenia. Curr Pharm Des 2011;17:112-120
-
(2011)
Curr Pharm Des
, vol.17
, pp. 112-120
-
-
Hashimoto, K.1
|